2m 2m 2m 2m 2m 2m 2m
Xenon Pharma (XENE)
NASDAQ
$67.10-$0.62 (-0.91%)
Price as of Jul 14, 2026 6:00 AM EDT- $6.5BMarket Cap
- 107.73%1-Year Change
- BiotechnologyIndustry
Xenon Pharma (XENE)
$67.10-$0.62 (-0.91%)
XENE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $67.72 | ||
Change | -$1.20 (-1.74%) | ||
Open | $67.79 | ||
High | $67.87 | ||
Low | $65.53 | ||
Previous Close | $68.92 | ||
Volume | 1,527,866 | ||
30-Day Average Volume | 2,050,813 | ||
1-Week Change | 11.86% | ||
1-Month Change | 29.98% | ||
1-Year Change | 107.73% | ||
3-Year Change | 77.79% | ||
5-Year Change | 270.46% | ||
Fundamentals | |||
Shares Outstanding | 96.7M | ||
Total Assets | $1.4B | ||
Market Cap | $6.5B | ||
Enterprise Value | $6.0B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$102.3M | ||
Free Cash Flow | -$89.0M | ||
EBIT | -$104.9M | ||
EBITDA | -$104.3M | ||
Net Working Capital | $1.1B | ||
EPS | -$1.17 | ||
Enterprise Value/EBITDA | -58 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -58 | ||
PEG | -5 | ||
Price/Free Cash Flow | -74 | ||
Price/Operating Cash Flow | -74 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue